Jupiter's de Blonay: Fintech is challenging behemoth banking sector

Are banks 'too big to change'?

clock • 4 min read

While interest rate increases have reignited interest in financials stocks, Guy de Blonay, manager of the Jupiter Financial Opportunities and International Financials funds, suggests the recovery story has become more complex given the challenge fintech companies are posing to the sector.

In recent weeks, the US Federal Reserve has outlined plans to reduce the size of its balance sheet, and increased the Fed funds rate by 0.25%, the second such move in six months with more expected. A tightening labour market has led to a more hawkish stance from chair Janet Yellen. Combined with the Trump effect, policy normalisation at the Fed has led to a rush towards cyclical financials - namely, banks. To some extent, this has come at the expense of specialist global payments and financial technology businesses. Kames' McEntegart boosts bank exposure ahead of rate hikes Banking...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot